With increased awareness people have become more aware of pneumonia complications but still a large number of kids are ...

CINCINNATI, Oct. 11, 2022 (GLOBE NEWSWIRE) -- Blue Water Vaccines Inc. (“BWV” or “Blue Water Vaccines” or the “Company”), a biopharmaceutical company developing transformational vaccines to address ...

World Pneumonia Day 2025 will be observed on November 12 to raise global awareness about pneumonia, its causes, symptoms, and ...

With pneumococcal diseases on the rise, doctors are urging adults to adopt a risk-based approach to immunisation. Preventive ...

Winter smog is severely impacting lung health and increasing risks of pneumococcal infections. Doctors stress vaccination as ...

Initiation of a first-in-man Phase I clinical trial in healthy subjects Study aims to obtain safety and immunogenicity data of this new vaccine candidate Initial results expected in Q4 2009 ...

Streptococcus pyogenes or invasive Group A Streptococcus (iGAS) is a major clinical concern around the world, since iGAS ...

Bacterial colonization in the upper respiratory tract is considered to be one of the major risk factors of COVID-19. In this context, studies have shown that the co-occurrence of invasive pneumococcal ...

Researchers have found a further reason for the severity of dual infection by influenza and Streptococcus pneumonia -- a new virulence mechanism for a surface protein on the pneumonia-causing bacteria ...

- Development of Intercell's Streptococcus pneumoniae vaccine supported by PATH VIENNA, April 7 /PRNewswire/ -- Intercell AG (VSE: ICLL) announced today that a Phase I clinical trial with the ...